Spherity Blog

OCI highlights a historic surge in ATP credentials with over 33,000 VRS requests in late 2025. Powered by Spherity and LedgerDomain, this milestone proves that automated DSCSA compliance is now a scalable reality for the pharmaceutical industry.

CARO v1.3 expands Spherity’s DSCSA solution into an ATP master data and communication hub. This FAQ answers the most common customer questions on deduplication, data updates, handling unverified records, and event driven notifications.

CARO v1.3 evolves from a VRS utility into an Authorized Trading Partner (ATP) master data and communication platform for DSCSA. This article breaks down what’s new—ATP and license checks, a governed address book, and auditable partner messaging—and outlines the long-term vision for CARO as Compliance-as-a-Service.

Spherity announced CARO v1.3, upgrading its DSCSA compliance software into an Authorized Trading Partner Master Data & Communication Hub for the US pharma supply chain.

This article analyzes two notable events in the US DSCSA from mid-December 2025: the FDA's Form 483 issuance to a Texas med spa and Louisiana's TR-WEEK initiative. It highlights key takeaways on FDA scrutiny across the supply chain, the effectiveness of ATP credentials in electronic tracing, and ongoing challenges surrounding GLNs.

Antares Vision Group expands its partnership with Spherity, becoming a reseller of ATP digital credentials to streamline DSCSA compliance, enhance identity verification, and strengthen supply chain security.

Discover four key takeaways from our DSCSA webinar covering Verification Router Service (VRS), Authorized Trading Partner (ATP) credentials, and interoperability as the November 27 deadline approaches.

Essentra Pharmacy adopts Spherity’s DSCSA ATP credentials early, enhancing patient safety and supply chain security ahead of the 2026 FDA deadline.

The solution for DSCSA Authorized Trading Partner (ATP) verification lies in automation. New technologies, such as the Verification Router Service (VRS) and digital ATP credentials, are changing the game. They enable real-time, automated verification, replacing slow, manual checks with a seamless, interoperable system.

Community pharmacy, Uptown Pharmacy, embraces Spherity’s digital credentials for enhanced efficiency and DSCSA compliance

AvKARE partners with Spherity to deploy ATP Credentials, boosting efficiency, fighting counterfeits, and ensuring DSCSA compliance.

R&S Northeast partners with Spherity to bring digital credentials to the pharmaceutical supply chain, helping ensure that every prescription drug product and trading partner is verified, secure, and DSCSA compliant.

Movilitas.Cloud launches free mobile app to streamline DSCSA verification, enabling fast 2D barcode scanning and instant VRS responses — powered by open digital credentials and backed by Movilitas.Cloud, Spherity, and LedgerDomain.

In May 2025, the Louisiana Board held its second public drug verification exercise—testing VRS, DSCSA Authority & ATP credentials ahead of the May 27 DSCSA exemption deadline. How did it compare to the first? What key insights did participants share?

DSCSA enforcement is finally here after multiple delays, and ATP credentials are essential for compliance, data protection, and cybersecurity. So, how is ATP credential adoption progressing — and where do we stand today?

As the pharma industry moves toward DSCSA compliance, the VRS Provider Network highlights concerns with GLN Allow Lists and how ATP digital credentials address them.

PDG and FDA hosted the first of three DSCSA town halls—explore key points, industry insights, and key takeaways from the session.

Pharma industry updates and key takeaways from the 15th Annual Pharma Serialization & Supply Chain 2025 and HDA DMC 2025.

If you're in digital credentialing, you're part of a global movement, investing in a future-proof, scalable tech. Let's explore examples!

OCI-conformant digital credentials seamlessly interoperable in public Verification Router Service (VRS) exercise.